These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8221092)

  • 1. Systemic or intracerebroventricular injection of NMDA receptor antagonists attenuates the antinociceptive activity of intrathecally administered NMDA receptor antagonists.
    Näsström J; Karlsson U; Berge OG
    Brain Res; 1993 Sep; 623(1):47-55. PubMed ID: 8221092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
    Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
    Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution of two NMDA receptor antagonists, [3H]CGS 19755 and [3H]MK-801, after intrathecal injection in mice.
    Näsström J; Böö E; Ståhlberg M; Berge OG
    Pharmacol Biochem Behav; 1993 Jan; 44(1):9-15. PubMed ID: 8430132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats.
    Luger TJ; Lorenz IH; Grabner-Weiss C; Hayashi T
    Br J Pharmacol; 1995 Mar; 114(5):1097-103. PubMed ID: 7780645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of MK-801 on the antinociceptive effect of [D-Ala(2),N-MePhe(4), Gly-ol(5)]enkephalin in diabetic mice.
    Zushida K; Kamei J
    Eur J Pharmacol; 2002 Jul; 448(1):39-44. PubMed ID: 12126969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.
    Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW
    Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy.
    Yamamoto T; Yaksh TL
    Neurosci Lett; 1992 Jan; 135(1):67-70. PubMed ID: 1311824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the NMDA receptor complex in DMCM-induced seizure in mice.
    Tsuda M; Suzuki T; Misawa M
    Neuroreport; 1997 Feb; 8(3):603-6. PubMed ID: 9106731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
    Hao JX; Xu XJ
    Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
    Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
    Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicative interaction between intrathecally and intracerebroventricularly administered morphine for antinociception in the mouse: involvement of supraspinal NMDA but not non-NMDA receptors.
    Suh HW; Song DK; Choi YS; Kim YH
    Life Sci; 1995; 56(8):PL181-5. PubMed ID: 7869834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites.
    Coderre TJ; Van Empel I
    Pain; 1994 Dec; 59(3):353-359. PubMed ID: 7708409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T
    J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist.
    Chen HS; Chen J
    Eur J Pain; 2000; 4(4):389-401. PubMed ID: 11124011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effect of smilaxin B administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Son KH; Woo MH; Do JC; Choi YS; Lee KH; Kim YH
    Planta Med; 1996 Apr; 62(2):141-5. PubMed ID: 8657747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal N-methyl-d-aspartate receptors may contribute to the immobilizing action of isoflurane.
    Stabernack C; Sonner JM; Laster M; Zhang Y; Xing Y; Sharma M; Eger EI
    Anesth Analg; 2003 Jan; 96(1):102-7, table of contents. PubMed ID: 12505933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil.
    Chizh BA; Reissmüller E; Schlütz H; Scheede M; Haase G; Englberger W
    Neuropharmacology; 2001; 40(2):212-20. PubMed ID: 11114400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
    Lu Y; France CP; Woods JH
    J Pharmacol Exp Ther; 1992 Nov; 263(2):499-504. PubMed ID: 1432686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of histamine receptor antagonists injected intrathecally on antinociception induced by opioids administered intracerebroventricularly in the mouse.
    Suh HW; Chung KM; Kim YH; Huh SO; Song DK
    Neuropeptides; 1999 Apr; 33(2):121-9. PubMed ID: 10657481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice.
    Furuya Y; Kagaya T; Ogura H; Nishizawa Y
    Eur J Pharmacol; 1999 Jan; 364(2-3):133-40. PubMed ID: 9932715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.